Skip to main content

Day: May 21, 2020

Charles & Colvard Reports Third Quarter Fiscal 2020 Financial Results

– Provides Business Update Related to COVID-19 –– Optimized Balance Sheet Provides Stability and Liquidity –– Conference Call with Accompanying Slide PresentationScheduled Today at 4:30 PM ET –RESEARCH TRIANGLE PARK, N.C., May 21, 2020 (GLOBE NEWSWIRE) — Charles & Colvard, Ltd. (Nasdaq: CTHR) (the “Company”), the original and leading worldwide source of created moissanite, reported financial results for the quarter ended March 31, 2020 (“Third Quarter Fiscal 2020”), with net sales of $6.5 million and net loss of $6.2 million, or $0.21 loss per diluted share, which included the write-off of $5.3 million of inventory associated with the Company’s legacy silicon carbide (SiC) material.Suzanne Miglucci, President and CEO of Charles & Colvard, said, “During these challenging times, we remain...

Continue reading

New York Mortgage Trust Reports First Quarter 2020 Results

NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three months ended March 31, 2020.Summary of First Quarter 2020:(dollar amounts in thousands, except per share data)(1) Economic return on book value is based on the periodic change in GAAP book value per common share plus dividends declared per common share, if any, during the period.Key Developments First Quarter of 2020:Experienced unprecedented market conditions resulting from the COVID-19 pandemic. In response, the Company took the following actions to manage its portfolio through the disruption and improve its liquidity:Sold all of our first loss multi-family POs and certain mezzanine CMBS securities issued by the Consolidated K-Series for total sales proceeds of...

Continue reading

Credit Acceptance Announces Timing of First Quarter 2020 Results and Webcast

Southfield, Michigan, May 21, 2020 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we expect to issue a news release with our first quarter 2020 results on Wednesday, May 27, 2020, after the market closes. A webcast is scheduled for Wednesday, May 27, 2020, at 5:00 p.m. Eastern Time to discuss first quarter 2020 results.  The webcast can be accessed live by visiting the “Investor Relations” section of our website at ir.creditacceptance.com or by dialing 877-303-2904.  Additionally, a replay and transcript of the webcast will be archived in the “Investor Relations” section of our website. Description of Credit Acceptance CorporationSince 1972, Credit Acceptance has offered financing programs that enable automobile dealers...

Continue reading

Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants

MENLO PARK, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock in an underwritten public offering. All of the securities in the proposed offering are to be sold by Geron. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Stifel and MTS Health Partners are acting as joint book-running managers for the proposed offering.A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock and accompanying warrants described above was previously filed...

Continue reading

TELUS partners with Alberta’s science centres to launch Virtual Summer Camps for Canadian youth

CALGARY, Alberta and EDMONTON, Alberta, May 21, 2020 (GLOBE NEWSWIRE) — Today, TELUS Spark, TELUS World of Science – Edmonton, TELUS, and Microsoft announced that they have joined forces to bring science camps online with the launch of Virtual Summer Camps powered by TELUS. As social distancing guidelines evolve at different paces throughout the country, these camps will ensure children across Canada will have access to a world-class STEM-based learning program this summer.Virtual Summer Camps powered by TELUS will be facilitated by the STEM experts at TELUS Spark and TELUS World of Science – Edmonton. TELUS has stepped up to provide funding, programming, Microsoft software and hardware, and other resources necessary to provide an effective, engaging experience for campers. Additionally, TELUS will provide connectivity...

Continue reading

Kane Biotech Announces First Quarter 2020 Financial Results

WINNIPEG, Manitoba, May 21, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2020 financial results.Recent Corporate Highlights:On February 20, 2020, the Kane Biotech appointed renowned Canadian veterinarian, Dr. Jean Gauvin, as Chief Veterinary Officer.On February 24, 2020, the Company closed a non-brokered private placement offering, issuing a total of 24,999,999 Units for aggregate gross proceeds of $3.5 million.On February 25, 2020, Kane Biotech signed its first U.S. distribution agreement with King Wholesale Inc.On February 26, 2020, the Company launched its silkstemTM anti-itch shampoo at the Global...

Continue reading

Sunrun Changes 2020 Annual Meeting of Stockholders to Virtual Format

SAN FRANCISCO, May 21, 2020 (GLOBE NEWSWIRE) — Sunrun Inc. (Nasdaq:RUN), the nation’s leading provider of residential solar, storage and energy services, today announced that the location and format of its 2020 Annual Meeting of Stockholders has been changed to a virtual-only meeting format, due to the impacts of COVID-19 and related public safety measures. Stockholders will not be able to attend the Annual Meeting in person.As previously announced, the Annual Meeting will be held on Tuesday, June 2, 2020 at 8:30 a.m. Pacific Time. There is no change to the items of business to be addressed at the Annual Meeting, which are described in Sunrun’s proxy materials previously made available to stockholders in connection with the Annual Meeting.Stockholders at the close of business on the record date, April 8, 2020, are entitled to participate...

Continue reading

Dynavax Technologies Announces Proposed Public Offering of Common Stock

EMERYVILLE, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.  Dynavax also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the common stock being offered in the public offering.  All of the shares in the offering will be sold by Dynavax. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Cowen, Evercore ISI and William Blair are acting as joint book-running managers for the offering....

Continue reading

County Bancorp, Inc. Announces Second Quarter Dividend

MANITOWOC, Wis., May 21, 2020 (GLOBE NEWSWIRE) — County Bancorp, Inc. (NASDAQ: ICBK), the parent company for Investors Community Bank, announced that on May 19, 2020 its Board of Directors declared a quarterly cash dividend of $0.07 per share. The dividend will be payable on June 19, 2020 to shareholders of record as of June 5, 2020. “We are very pleased to be able to maintain our dividend payment in these unprecedented times.  It reflects our commitment to returning shareholder value, as well as our confidence in our future outlook,” stated Tim Schneider, President of the Company and CEO of the Bank. About County Bancorp, Inc.

Continue reading

Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates

Geron plans to move forward with a Phase 3 clinical trial in refractory myelofibrosis (MF) with overall survival (OS) as a primary endpoint, which is expected to open for screening and enrollment in first quarter 2021Completion of patient enrollment for the ongoing IMerge Phase 3 clinical trial in lower risk myelodysplastic syndromes (MDS) is expected first quarter 2021Revised operating expense guidance of $70 – $75 million for 2020Conference call scheduled for Thursday, May 28 at 4:30 p.m. ETMENLO PARK, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced plans for a Phase 3 clinical trial in MF patients who are refractory to treatment with a janus kinase (JAK) inhibitor, including trial design and expected timelines for trial start and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.